If you’ve never heard of the endocannabinoid system (ECS), not to worry - most people haven’t. Finding out that the body already makes its own cannabinoids, called endocannabinoids, is a genuine aha moment for many, and a fair one. It’s also usually followed by this question:
If the body is already doing this - why do I need Provacan?
It's a great question, and it deserves a straight answer rather than a sales pitch.
Answering it properly means going back a step: what are endocannabinoids, and why isn’t the body’s own supply always enough? It also means tackling the question that often sits right behind it: does CBD actually do anything?
This article walks through what endogenous (self-built) cannabinoids are, why the body's own supply isn't quite as good and reliable as it sounds, how that compares to plant-derived cannabinoids like CBD, and what the current evidence shows.
What are endocannabinoids, exactly?
"Endogenous" simply means made-by-the-body. So what cannabinoids does the body produce, and where do they come from? The ECS produces its own cannabinoids - most notably anandamide and 2-AG - which act on the same receptor network that plant cannabinoids interact with (3).
Anandamide gets most of the attention thanks to its “bliss molecule” nickname, but 2-AG is found in much higher levels in the brain and does a lot of the ECS’s day-to-day heavy lifting (3).
You can read more about how the ECS works and what anandamide does on our previous articles.
For now, the short version is that - it’s true, everyone already has a working cannabinoid system, and yes – the body produces cannabinoids (3).

Does your body produce CBD?
No, and it’s a common mix-up. CBD is made by the hemp plant, not by you. What your body makes are endocannabinoids: a different family of compounds that work through the same system. That distinction is the root of this whole question.
So if my body already makes cannabinoids... why isn't that enough?
Here's the kicker: unfortunately, endogenous cannabinoids aren't stored up the way vitamins are. They're made on demand, in small amounts, used quickly, and broken down almost as fast - anandamide, for instance, is metabolised rapidly by an enzyme called FAAH. There's no reserve tank sitting there waiting to be drawn on (3). In other words, endogenous cannabinoids are less like savings in the bank and more like cash in hand: made when needed, spent almost immediately.
That system also isn't fixed in how well it performs. What's sometimes referred to as "endocannabinoid tone" can dip under chronic stress, poor sleep, ageing and general modern-life wear and tear - the same pressures that can affect cortisol and homeostasis more broadly. When those systems are already under strain, it stands to reason that the ECS may not operate at its best either (2,3).
For a proportion of the population, this under-performance appears to be more persistent rather than situational - an idea explored in Clinical Endocannabinoid Deficiency. Particularly for those living with fibromyalgia, suffering with migraines or experiencing IBS type symptoms, it’s worth a read (2).

Endogenous vs plant cannabinoids: what's actually different
Phytocannabinoids are cannabinoids made by plants. Hemp produces more than 100 of them, with CBD being the best known. Phytocannabinoids come from outside the body and behave differently once they're in the system (1,3).
Endocannabinoids, such as anandamide and 2-AG, are made inside the body, used locally, and broken down quickly.
| Endocannabinoids | Phytocannabinoids | |
|---|---|---|
| Made by | Your body | Plants, such as hemp |
| Examples | Anandamide, 2-AG | CBD, CBG, CBN |
| How they're made | On demand, where needed | Taken in from outside the body |
| How long they last | Very short-lived, broken down fast | Longer, processed by the body over hours |
How does CBD work?
Here's the clarification that tends to surprise people: CBD doesn't simply "top up" anandamide levels the way, say, taking vitamin D tops up a vitamin D deficiency. It's understood to work more indirectly - for example, by slowing down the FAAH enzyme responsible for breaking anandamide down, and by interacting with the ECS more broadly rather than directly replacing what the body makes (1).
It's less like refilling a tank, and more like easing the pressure on a system that's already working in overtime.
Does CBD actually do anything, then?
The language used in this section is deliberately careful, and that's not about being cagey - it's what UK regulations require of any CBD brand. Under UK regulations, CBD brands cannot legally say that CBD treats, cures or prevents anything, or claim that it has specific physiological effects without appropriate authorisation (4).
Consumers should be sceptical of any UK brand that isn't following the same rules.
What that means in practice is that the language stays in "research suggests" and "may support" territory throughout - not because of unnecessary hedging, but because that's an honest reflection of where the science currently sits.
Research is actively exploring FAAH inhibition, receptor interaction, and the broader idea of ECS modulation, and some of it is genuinely promising (1,3). But "promising and being studied" is different from "proven to treat a condition", and that distinction matters when discussing CBD from an evidence-based nutrition perspective.
A sceptical, evidence-first answer is more useful than an enthusiastic one.
But a note to add from my experience as a Nutritional Therapist working in the CBD industry - many of my clients feel the difference with Provacan.
Is CBD the only way to support your ECS?
No, not necessarily. CBD is the best-known plant compound that interacts with the ECS, but it isn't the only one being studied. Certain plant terpenes - beta-caryophyllene, found in hops, is one example - are also being researched for how they interact with cannabinoid receptors (1,3).
The detail won't be explored here, because the research in this area is still early. But it's worth flagging: this is an area that we’ll be exploring in more depth over the coming months, as interest in ECS support beyond CBD continues to grow.
And it’s not only about what you take. Sleep, movement and how you manage stress all influence endocannabinoid tone too.

Final thoughts: supplementing isn't fixing a broken system, it's supporting a busy one
The ECS is real, and it's working right now, whether or not someone has ever thought about it. It's also under more pressure than many people realise - from stress, sleep, and the general demands of modern life.
Supporting it isn't contradicting human biology. It's about working with it.
Ready to support yours? Explore our ECS-support range, take our Wellbeing Quiz to find your best fit, or book a free consultation for one-to-one advice.
Disclaimer:CBD is not intended to diagnose, treat, cure, or prevent any disease. While research into CBD is promising, some studies have shown mixed results compared to placebos. Anyone considering starting a new supplement, especially when taking other medications, should consult their doctor first.
Sources
- Pertwee, R.G., 2008. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. British Journal of Pharmacology, 153(2), pp.199-215.
- Russo, E.B., 2016. Clinical endocannabinoid deficiency reconsidered: current research supports the theory in migraine, fibromyalgia, irritable bowel, and other treatment-resistant syndromes. Cannabis and Cannabinoid Research, 1(1), pp.154-165.
- de Melo Reis, R.A., Isaac, A.R., Freitas, H.R., de Almeida, M.M., Schuck, P.F., Ferreira, G.C., Andrade-da-Costa, B.L.S. and Trevenzoli, I.H., 2021. Quo vadis? Specific functions of the endocannabinoid system in the brain and beyond. Frontiers in Neuroscience, 15, 700434.
- Advertising Standards Authority, n.d. CAP Code: rules on health, beauty and slimming. https://www.asa.org.uk/type/non_broadcast/code_section/12.html




